7 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 ... recommendations for the treatment ... the use of this medication ... won’t have any clinical ... #Pharmacology #
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... disease b) CHF ... Change in clinical ... Determine if any labs ... unless prior heart/lung
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... effects in the treatment ... Weaknesses: Limited clinical ... #agents #medications ... Coccidioidomycosis #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Overview of antifungal ... effects in the treatment ... tolerable • Limited clinical ... #antifungals #comparison ... #table #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... & Dry) is the treatment ... #heartfailure #chf ... #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... salivary ducts Clinical ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... lubricants • Pharmacologic
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
has five major clinical ... Diagnosis: • Labs ... fungal stain of clinical ... change in the lungs ... nails, bronchi, lungs